XT
NDRA icon

XTX Topco’s ENDRA Life Sciences NDRA Stock Holding History

XTX Topco’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8
Closed -$1.44K – 2425
2024
Q2 		$1.44K Buy
8
+2
+33% +$861 ﹤0.01% 1778
2024
Q1 		$6.24K Buy
+6
New +$11.8K ﹤0.01% 1705

Other funds holding NDRA

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's NDRA Position: Q3 2024 in Review

XTX Topco sold out of ENDRA Life Sciences (NDRA) in Q3 2024, closing a stake of 8 shares — an estimated $1.44K sold.

XTX Topco first reported a position in NDRA in Q1 2024 and held it in 2 quarters. The position peaked at $6.24K in Q1 2024. 9 funds tracked by Wall St. Rank hold NDRA as of Q3 2024.

  • XTX Topco reported no remaining ENDRA Life Sciences position as of Q3 2024 after selling out during the quarter.
  • XTX Topco sold 8 ENDRA Life Sciences shares in Q3 2024, an estimated $1.44K.
  • XTX Topco first reported a position in ENDRA Life Sciences in Q1 2024 and held it in 2 quarters.
  • XTX Topco's ENDRA Life Sciences position peaked at $6.24K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.